Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
34.06
+2.74 (8.75%)
Oct 19, 2026, 1:15 PM EDT - Market open
Agios Pharmaceuticals Employees
As of December 31, 2025, Agios Pharmaceuticals had 540 total employees, including 539 full-time and 1 part-time employees. The number of employees increased by 52 or 10.66% compared to the previous year. That makes Agios Pharmaceuticals the 19,493rd largest employer in the world and 2,628th in the United States.
Employees
540
Change (1Y)
52
Growth (1Y)
10.66%
Revenue / Employee
$182,107
Profits / Employee
-$761,641
Market Cap
2.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 540 | 52 | 10.66% | 539 | 1 |
| Dec 31, 2024 | 488 | 102 | 26.42% | 486 | 2 |
| Dec 31, 2023 | 386 | -7 | -1.78% | 383 | 3 |
| Dec 31, 2022 | 393 | 1 | 0.26% | 389 | 4 |
| Dec 31, 2021 | 392 | -170 | -30.25% | 390 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Vera Therapeutics | 361 |
| Immunome | 247 |
| Zymeworks | 231 |
| Lakefront Biotherapeutics NV | 196 |
| Pharvaris | 148 |
AGIO News
- 11 days ago - Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8:00 a.m. ET - GlobeNewsWire
- 12 days ago - Agios Pharmaceuticals price target lowered to $37 from $39 at Truist - TheFly
- 4 weeks ago - Agios Pharmaceuticals price target raised to $50 from $46 at BofA - TheFly
- 2 months ago - Agios Pharmaceuticals price target raised to $52 from $46 at Citi - TheFly
- 2 months ago - Agios Pharmaceuticals price target raised to $55 from $52 at H.C. Wainwright - TheFly
- 2 months ago - Agios Pharmaceuticals Transcript: Transcript - Transcripts
- 2 months ago - Agios Pharmaceuticals Quarterly report - Filings
- 2 months ago - Agios Pharmaceuticals Slides - Filings